Growth Metrics

ClearPoint Neuro (CLPT) Shareholder's Equity (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -32.76%
Dec 31, 2025 76.52%
Sep 30, 2025 -19.60%
Jun 30, 2025 -1.22%
Mar 31, 2025 -21.28%
Dec 31, 2024 -12.45%
Sep 30, 2024 -9.74%
Jun 30, 2024 -7.09%
Mar 31, 2024 63.34%
Dec 31, 2023 -12.12%
Sep 30, 2023 -12.10%
Jun 30, 2023 -15.87%
Mar 31, 2023 -11.68%
Dec 31, 2022 -7.50%
Sep 30, 2022 -6.87%
Jun 30, 2022 -6.36%
Mar 31, 2022 -6.27%
Dec 31, 2021 10.58%
Sep 30, 2021 -8.02%
Jun 30, 2021 9.06%
Mar 31, 2021 1,750.32%
Dec 31, 2020 1,495.30%
Sep 30, 2020 -88.87%
Jun 30, 2020 -51.47%
Mar 31, 2020 -39.84%
Dec 31, 2019 -23.67%
Sep 30, 2019 -13.02%
Jun 30, 2019 1,460.52%
Mar 31, 2019 -70.69%
Dec 31, 2018 -39.42%
Sep 30, 2018 -29.97%
Jun 30, 2018 -25.06%
Mar 31, 2018 -18.52%
Dec 31, 2016 -231.59%
Sep 30, 2016 114.49%
Jun 30, 2016 -9.70%
Mar 31, 2016 -82.42%
Dec 31, 2015 65.97%
Sep 30, 2015 1.00%
Jun 30, 2015 -62.01%
Mar 31, 2015 -3,518.17%
Dec 31, 2014 98.73%
Sep 30, 2014 -75.82%
Jun 30, 2014 -43.69%
Mar 31, 2014 54.08%
Dec 31, 2013 -21.77%
Sep 30, 2013 -99.09%
Jun 30, 2013 -50.65%
Mar 31, 2013 76.21%
Dec 31, 2012 16.52%
Sep 30, 2012 12.22%
Jun 30, 2012 15.51%
Mar 31, 2012 41.84%